CorMedix (CRMD) Asset Utilization Ratio (2016 - 2026)
CorMedix (CRMD) posted Asset Utilization Ratio of 0.4 for Q4 2025, down 7.45% sequentially from 0.43 in Q3 2025, and down 10.75% YoY from 0.44 in Q4 2024.
CorMedix (CRMD) Asset Utilization Ratio (2016 - 2026) Analysis & Trends
CorMedix has reported Asset Utilization Ratio for 9 years, with the latest figure at 0.4 in Q4 2025.
- Quarterly Asset Utilization Ratio fell 10.75% year-over-year to 0.4 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.4 (down 10.75% YoY) and the FY2025 annual result came in at 0.66, up 52.44% from the prior year.
- Asset Utilization Ratio slipped to 0.4 in Q4 2025 per CRMD's latest filing, from 0.43 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.62 in Q1 2025 and troughed at 0.0 in Q4 2022.
- A 4-year average of 0.18 and a median of 0.0 in 2021 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2021 and 2025: Asset Utilization Ratio slumped 62.43% in 2021, then soared 4297.05% in 2025.
- Over 4 years, Asset Utilization Ratio stood at 0.0 in 2021, then tumbled by 60.16% to 0.0 in 2022, then soared by 41923.06% to 0.44 in 2024, then fell by 10.75% to 0.4 in 2025.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.4, 0.43, and 0.6 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.13 |
| 10 | CorMedix | 645.20 Mn | 388.51 Mn | 77.13 Mn | 0.43 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.43 |
| Dec 31, 2025 | 0.40 |
| Sep 30, 2025 | 0.43 |
| Jun 30, 2025 | 0.60 |
| Mar 31, 2025 | 0.62 |
| Dec 31, 2024 | 0.44 |
| Sep 30, 2024 | 0.18 |
| Jun 30, 2024 | 0.01 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 0.00 |
| Mar 31, 2021 | 0.00 |
| Dec 31, 2020 | 0.01 |
| Sep 30, 2020 | 0.01 |
| Jun 30, 2020 | 0.01 |
| Mar 31, 2020 | 0.01 |